Skip to content

Study of Low Bone Mass in Premenopausal or Perimenopausal Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00005101
Enrollment
Unknown
Registered
2000-04-07
Start date
1998-02-28
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

disease-related problem/condition, osteoporosis, rare disease

Brief summary

OBJECTIVES: I. Determine the possible causes of bone loss in premenopausal or perimenopausal women.

Detailed description

PROTOCOL OUTLINE: Patients undergo physical examination and complete history with emphasis on risk factors for osteoporosis and screening for occult secondary causes of osteoporosis through blood serum and 24 hour urine collection. Patients with more than 6 months since prior bone mineral density measurements or who did not receive measurements at participating center, undergo dual energy x-ray absorptiometry over 30 minutes for bone mineral density measurements.

Interventions

None listed

Sponsors

Columbia University
CollaboratorOTHER
National Center for Research Resources (NCRR)
Lead SponsorNIH

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 54 Years
Healthy volunteers
No

Inclusion criteria

PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- * Low bone mass (T score less than -2.0) with no secondary cause on routine exam * Premenopausal OR * Perimenopausal --Prior/Concurrent Therapy-- * Chemotherapy: No prior or concurrent chemotherapeutic agents * Endocrine therapy: No prior or concurrent glucocorticoids or suppressive doses of thyroid hormone * Other: No prior or concurrent anticonvulsants --Patient Characteristics-- * Hematopoietic: No multiple myeloma * Other: No hyperparathyroidism No thyrotoxicosis No anorexia nervosa No Paget's disease of bone No rheumatoid arthritis No Cushing's syndrome No malabsorption syndrome No type I diabetes mellitus

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026